BioSpace News Archive

iCAD, Inc. today announced the availability of the company’s Xoft® Axxent® Electronic Brachytherapy (eBx®) System® at Sanford USD Medical Center.

Presentation by Dr. Michio Hirano on Mitochondrial DNA Depletion Disorders will Highlight Clinical Data on Treatment of Thymidine Kinase 2 Deficiency with Deoxynucleoside Therapy.

Data from Large Natural History Study Show Strong Correlation of Lower Leg Composite MRI T2 with DMD Disease Progression, Supporting Positive Edasalonexent Effects in the MoveDMD® Trial

Kala Pharmaceuticals, Inc. announced today the pricing of an underwritten public offering of 7,500,000 shares of its common stock at a public offering price of $8.25 per share, before offering discounts.

- In its first year, the Express Scripts Diabetes Care Value program delivered nearly $43 million savings for plans; reduced heart attack risk in 15 percent of patients

TraceLink Inc. today announced that it now serves over 1,000 customers in 43 countries, delivering proven solutions for companies that are complying with U.S. Drug Supply Chain Security Act (DSCSA), EU Falsified Medicines Directive (FMD) and additional track and trace requirements in Russia, India, South Korea, China and Brazil.

Zosano Pharma Corporation today announced a manufacturing and supply agreement for M207 with a leading global contract development and manufacturing organization, which serves more than 400 clients in the pharmaceutical and biotechnology sectors.

Vikor Scientific and Sanford Guide announce the release of a new integrated product that combines advanced molecular diagnostics with industry-leading infectious disease treatment guidelines.

Panel to Highlight Advanced Therapeutics for Oncology

GB Sciences explores the therapeutic potential of the chemical diversity within different varieties of the cannabis plant to make better medicine for patients worldwide.